Revolutionizing FSGS: Addressing Proteinuria & GFR as Clinical Endpoints in FSGS Through the PARASOL Initiative
Time: 11:30 am
day: Pre-Conference Focus Day
Details:
- Explore the current challenges in identifying reliable, meaningful endpoints in FSGS clinical trials, and how the PARASOL initiative seeks to establish the relationship between short-term biomarker changes (proteinuria and GFR) and long-term outcomes
- Exploring how global patient registries and real-world data from diverse cohorts are informing endpoint identification, particularly in rare diseases like FSGS where patient numbers are limited
- Examine the implications of newly identified endpoints on clinical trial design, regulatory approval, and future therapeutic development for FSGS, with lessons for broader glomerular diseases.